Lv3
392 积分 2022-10-10 加入
Nogapendekin alfa Inbakicept: First Approval
3天前
已完结
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
3天前
已完结
Nogapendekin alfa Inbakicept: First Approval
10天前
已完结
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
18天前
已完结
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
21天前
已完结
EP.03E.02 Elucidation of Trastuzumab-Deruxtecan Resistance Mechanisms using in Vivo Xenograft Model Reflecting Pharmacokinetics
22天前
已关闭
Diagnosis and Treatment of Metastatic Colorectal Cancer
22天前
已完结
Abstract 5857: Trastuzumab deruxtecan resistance can be mediated by payload resistance or secondary extracellular ERBB2 mutations but sensitivity to HER2 tyrosine kinase inhibitors is maintained
23天前
已关闭
Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non–Small-Cell Lung Cancer: Case Series
23天前
已完结
皖公网安备34019202002308
